iShares US Pharmaceuticals ETF
IHE
IHE
101 hedge funds and large institutions have $98.4M invested in iShares US Pharmaceuticals ETF in 2021 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 25 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
101
Holders Change
–
Holders Change %
0%
% of All Funds
1.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
29
Reduced
25
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$7.47M |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$4.17M |
| 3 |
3
Wells Fargo
San Francisco,
California
|
$11.2M |
| 4 |
BPA
4
Beacon Pointe Advisors
Newport Beach,
California
|
$991K |
| 5 |
5
Morgan Stanley
New York
|
$8.47M |
